Array Biopharma Higher After Q4 Beat

Array Biopharma Inc ARRY shares are trading higher by $1.16 (10 percent) at $11.86 in Thursday's session. Before the open, the company announced a Q4 EPS beat of $0.04 along with a $15.23 million beat for sales.

After a higher open, it retreated but found support just ahead of Wednesday's close ($10.70) only reaching $10.81 before continuing its move higher. So far, the ensuing rally has taken the issue to $12.08, but has fallen back into the $11.00 handle.

This marks the highest level for the issue since December 2007 when it peaked at $12.45, but faltered to end that year at $8.42.